During the past decade, Universita degli Studi di Torino - Centro Regionale Esperto Per La Sclerosi Laterale Amiotrofica (CRESLA) conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universita degli Studi di Torino - Centro Regionale Esperto Per La Sclerosi Laterale Amiotrofica (CRESLA)" #1 collaborator was "University of Modena and Reggio Emilia" with 2 trials as a collaborator, "University of Padova" with 2 trials as a collaborator, "University of Turin, Italy" with 2 trials as a collaborator, "Azienda Ospedaliera Niguarda Cà Granda" with 1 trials as a collaborator and "Azienda Ospedaliero Universitaria Maggiore della Carita" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Universita degli Studi di Torino - Centro Regionale Esperto Per La Sclerosi Laterale Amiotrofica (CRESLA)" are "ALS" (2 trials), "Amyotrophic Lateral Sclerosis" (2 trials) and "Amyotrophic Lateral Sclerosis (ALS)" (1 trials). Many other conditions were trialed in "Universita degli Studi di Torino - Centro Regionale Esperto Per La Sclerosi Laterale Amiotrofica (CRESLA)" in a lesser frequency.

Most popular intervention types in "Universita degli Studi di Torino - Centro Regionale Esperto Per La Sclerosi Laterale Amiotrofica (CRESLA)" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "MT-1186" (3 trials), "Placebo Oral Tablet" (2 trials), "Colchicine 1 MG Oral Tablet" (1 trials), "Placebo" (1 trials) and "Rapamycin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universita degli Studi di Torino - Centro Regionale Esperto Per La Sclerosi Laterale Amiotrofica (CRESLA)" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Universita degli Studi di Torino - Centro Regionale Esperto Per La Sclerosi Laterale Amiotrofica (CRESLA)". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Universita degli Studi di Torino - Centro Regionale Esperto Per La Sclerosi Laterale Amiotrofica (CRESLA), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universita degli Studi di Torino - Centro Regionale Esperto Per La Sclerosi Laterale Amiotrofica (CRESLA), 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".